Liquidia soars 27% after settlement resolves litigation (LQDA:NASDAQ)
seekingalpha.com · 2026-10-14
Liquidia (LQDA) surges after settling United Therapeutics litigation, lifting uncertainty around YUTREPIA.
Read the full story at seekingalpha.com →
Is LQDA undervalued? See TickrTrends' fair value analysis →